asco 2018 overview: luciano costa, md
Published 6 years ago • 832 plays • Length 7:36Download video MP4
Download video MP3
Similar videos
-
5:50
luciano costa | asco 2018 | phase ii study of venetoclax, carfilzomib and dexamethasone in rrmm
-
3:46
overview of multiple myeloma clinical trials presented at asco 2018
-
4:05
top multiple myeloma research presented at asco 2018
-
3:47
le myélome multiple asco 2018 faits saillants
-
2:29
majestic-1 study -a subgroup analysis of high-risk patients | luciano costa, md | eha2024
-
7:22
asco and eha overview of top multiple myeloma abstracts and posters
-
2:33
top five promising multiple myeloma research presented at asco 2018
-
1:03:56
top myeloma research presented at asco & eha
-
1:02:01
top myeloma research presented at asco & eha 2024
-
42:46
imf patient & family webinar 2023 - frontline therapy
-
3:29
preliminary results of mezigdomide combinations in rrmm patients | luciano costa, md, phd | ims 2024
-
58:26
myeloma updates 2018: best of asco/eha/imwg
-
5:13
ash 2018: top multiple myeloma research
-
5:05
luciano costa: evaluating a venetoclax and carfilzomib combination in myeloma
-
4:35
asco 2019: new bite update on amg-420 with dr. luciano costa
-
3:55
optimizing outcomes in early car-t therapy | luciano costa, md, phd | ims 2024
-
1:01:57
today's car t options in multiple myeloma care with luciano costa, md, uab
-
3:38
luciano costa, md, discusses results from cartitude-4 subanalysis
-
4:26
phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with rr multiple myeloma
-
4:17
asco 2019: cereblon inhibitor with dr. luciano costa
-
1:00:01
myeloma crowd radio: luciano costa, md, phd, university of alabama